Latest Biotech News

Sanofi expanded its venture capital arm with a $625 million cash infusion to invest in biotech startups, reflecting a focus on advancing scientific innovation amid tight capital markets....

Merck has entered a collaboration with Variational AI, investing up to $349 million to apply cutting-edge generative AI models for designing novel small molecule therapeutics targeting undisclosed...

MBX Biosciences announced positive top-line phase 2 data for canvuparatide in chronic hypoparathyroidism, meeting its primary endpoint and demonstrating significant improvements in adults. The...

Roche announced a significant phase 3 trial win for its selective estrogen receptor degrader (SERD) in a broad breast cancer population, outperforming standard-of-care treatments. This advancement...

Researchers have developed an innovative PET tracer targeting the protein nectin-4, commonly overexpressed in triple-negative breast cancer and urothelial bladder carcinoma. This new tracer...

Pfizer has agreed to acquire Metsera for an initial payment of $4.9 billion, with additional milestone payments potentially raising the total to $7.3 billion. This acquisition brings a diverse...

The U.S. FDA has approved Merck's Keytruda Qlex, the first subcutaneously administered immune checkpoint inhibitor for solid tumors, enabling dosing in about one minute. This rapid administration...

Ionis Pharmaceuticals has reported positive top-line results from a pivotal Phase 3 study evaluating zilganersen, an antisense oligonucleotide for Alexander disease, a rare and fatal inherited...

The FDA has issued a complete response letter rejecting Scholar Rock’s apitegromab, intended for spinal muscular atrophy (SMA), due to unresolved manufacturing problems at a contract facility...

Roche has unveiled a strategic plan to become a leading obesity company by 2030 without relying on a single blockbuster drug. The plan leverages multiple pipeline assets, including the dual...

Merck has entered a $349 million collaboration with Variational AI to accelerate small molecule drug discovery via generative artificial intelligence. The partnership will deploy Variational AI’s...

Researchers at Children’s Mercy Kansas City published data demonstrating that clinical long-read whole-genome sequencing (WGS) increases diagnostic yield to 37% compared to 27% for conventional...

Scientists from the National University of Singapore and Central South University have engineered gut bacteria that enhance immune response against colorectal cancer. This synthetic biology...

Researchers have developed a novel positron emission tomography (PET) tracer targeting nectin-4, allowing same-day immuno-PET imaging of triple-negative breast cancer and urothelial bladder...

Pfizer has agreed to acquire Metsera for an initial $4.9 billion, with potential additional contingent value rights pushing the total deal up to $7.3 billion. Metsera’s pipeline includes...

The U.S. FDA has approved Merck’s Keytruda Qlex, a subcutaneous formulation of the blockbuster immunotherapy, enabling administration in about one minute compared to the 30-minute intravenous...

Ionis Pharmaceuticals reported positive pivotal Phase 3 trial results for zilganersen, an antisense oligonucleotide for Alexander disease, a rare and fatal neurogenetic disorder with no prior...

Scholar Rock’s application for apitegromab, a selective anti-latent myostatin antibody targeting spinal muscular atrophy (SMA), was rejected by the FDA due to unresolved quality control problems...

A collaborative research effort by University of Massachusetts Amherst and Jiangnan University has demonstrated a novel method to enhance rice nutrition and yield while reducing fertilizer usage....

Merck & Co. has expanded its partnership with Variational AI through a deal potentially worth $349 million, focusing on applying the Enki generative AI platform to design novel small molecule...